Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quidel re-launches infectious mononucleosis test

This article was originally published in Clinica

Executive Summary

Quidel has re-launched its QuickVue+ lateral flow test for infectious mononucleosis in response to "strong customer demand". The San Diego, California firm stopped manufacturing the test in August 2007 "due to a heavy investment required to maintain the production line", it told Clinica. "At the time, we had a variety of other projects that provided us with a better long-term opportunity. After completion [of these], we turned our attention back to the mono product." Infectious mononucleosis, also known as mono and glandular fever, is caused by the Epstein-Barr virus and spread via saliva. Quidel's test provides results in five minutes and detects immunoglobulin M (IgM), an antibody that appears early in the course of infection.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel